FDA issued a Warning Letter to Cadila Healthcare Limited on 6/21/2011 as a result of this inspection.
483 Cadila Healthcare Feb 2011

483 Cadila Healthcare Feb 2011

Charles Cote FDA, Susan Jackson FDA$119.00 - Available Now

FDA investigators audited the Cadila Healthcare - Ahmedabad, India facility and issued inspectional observations (via FDA 483) on 03 Feb 2011.

Product details

  • Category: Human Drugs
  • Inspection end: 03 Feb 2011
  • Location: Ahmedabad, India
  • FEI: 3002984011
Add To Cart